MSA
MLAB icon

Marino Stram & Associates’s Mesa Laboratories MLAB Stock Holding History

Marino Stram & Associates’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20
Closed -$5K – 380
2019
Q1 		$5K Buy
20
+3
+18% +$678 ﹤0.01% 377
2018
Q4 		$4K Buy
+17
New +$3.31K ﹤0.01% 366

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Marino Stram & Associates's MLAB Position: Q2 2019 in Review

Marino Stram & Associates sold out of Mesa Laboratories (MLAB) in Q2 2019, closing a stake of 20 shares — an estimated $5K sold.

Marino Stram & Associates first reported a position in MLAB in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 125 funds tracked by Wall St. Rank hold MLAB as of Q2 2019.

  • Marino Stram & Associates reported no remaining Mesa Laboratories position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 20 Mesa Laboratories shares in Q2 2019, an estimated $5K.
  • Marino Stram & Associates first reported a position in Mesa Laboratories in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's Mesa Laboratories position peaked at $5K in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.